#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome HER2 gene amplification Primary adrenal insufficiency Non-renal cell carcinoma of kidney Pleomorphic leiomyosarcoma Skin cancer Squamous cell carcinoma of the hypopharynx Frostbite Philadelphia chromosome positive Mantle cell lymphoma stage II Polyneuropathy Paraneoplastic neurological syndrome Hypergammaglobulinaemia benign monoclonal Dedifferentiated liposarcoma Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Pleural mesothelioma malignant – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Medulloblastoma – Diagnostics Krabbe’s disease – Life with Disease Urea cycle disorder – Diagnostics Bronchopulmonary dysplasia – Life with Disease Castleman’s disease – Trials in Disease Pemphigus – Trials in Disease Acquired haemophilia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fezolinetant ARLOCABTAGENE AUTOLEUCEL Cart45Ra-Nkg2D Cells Ziclumeran Metolazone Human Coagulation Factor Viii Sotorasib Cimetidine Hydrochloride Benztropine Mesylate Bedaquiline Vincristine Sulfate Idursulfase Ondansetron Hydrochloride Rbl012.2 Verapamil Tamuzimod Acetate Tipapkinogene Sovacivec Diazepam Blomia Tropicalis Imidapril Hydrochloride More therapies…

    Learn about Your Condition

    Urea cycle disorder Post-acute COVID-19 syndrome Thermal burn Ureteric cancer Metastatic malignant melanoma Colorectal cancer stage IV Hepatotoxicity Hand dermatitis Urethral stenosis Herpes simplex reactivation Mitral valve prolapse Colorectal cancer stage III Gastrectomy Leukaemia Pericarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Benign prostatic hyperplasia

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    • Prostate cancer
    Investigated Drugs:
    • Dutasteride
    • Finasteride
    • Tamsulosin Hydrochloride
    Finland

  • Effect of serenoa repens on chronic prostate inflammation in men with benign prostatic hyperplasia: a phase III randomized study

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Italy

  • Study on Antibiotic Treatment Before Surgery for Benign Prostate Hyperplasia: Fosfomycin Calcium, Bromhexine Hydrochloride, Sulfamethoxazole, and Trimethoprim

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Investigated Drugs:
    • FOSFOMYCIN CALCIUM
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France

  • Study on the Safety and Effectiveness of Oxitriptan and Tamsulosin Hydrochloride for Patients with Benign Prostatic Hyperplasia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Investigated Drugs:
    • Oxitriptan
    • Tamsulosin Hydrochloride
    Portugal

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!